Paroxysmal Hemicrania Symptoms
Paroxysmal hemicrania is characterized by severe, strictly unilateral headache attacks lasting 2-30 minutes with ipsilateral cranial autonomic features, occurring multiple times daily, and showing an absolute response to indomethacin.
Clinical Presentation
Core Symptoms
Pain Characteristics:
- Strictly unilateral pain (typically orbital, temporal, and frontal)
- Severe intensity
- Short-lasting attacks (mean duration of 17 minutes)
- High frequency (mean of 11 attacks per day, typically >5 daily)
- Rapid onset and cessation
Cranial Autonomic Features (ipsilateral to pain):
Behavioral Responses:
Pain Distribution
While predominantly in the orbital-temporal region (77%), pain can also be reported in:
- Retro-orbital area (61%)
- Frontal region (55%)
- Occipital region (42%)
- Other areas: vertex, jaw, teeth, neck, shoulder 1
Diagnostic Criteria Considerations
The hallmark feature that distinguishes paroxysmal hemicrania from other primary headache disorders is its absolute response to indomethacin 1, 2. This response is so characteristic that it is considered a diagnostic criterion.
However, clinical presentation may vary:
- Some patients may lack cranial autonomic features 2
- Some may have fewer than 5 attacks per day 2
- Some may have incomplete response to indomethacin 2
- Some may be unable to tolerate indomethacin due to side effects 3, 4
Diagnostic Challenges
Overlap with Other Headache Disorders
There may be overlap between paroxysmal hemicrania and cluster headache, with some patients showing features of both conditions 3. The key differences include:
| Feature | Paroxysmal Hemicrania | Cluster Headache |
|---|---|---|
| Duration | 2-30 minutes | 15-180 minutes |
| Frequency | >5 attacks daily | 1-8 attacks daily |
| Gender | Female predominance | Male predominance |
| Indomethacin response | Absolute | Variable/Poor |
Secondary Causes
Always consider secondary causes of paroxysmal hemicrania-like symptoms, especially with:
- Atypical clinical features
- Poor response to indomethacin
- Abnormal neurological examination
- Onset after age 50
Management Approach
- First-line treatment: Indomethacin (100-200 mg daily) 1
- For indomethacin-intolerant patients: Consider topiramate as an alternative 4
Clinical Pearls
- The indomethacin test (oral or intramuscular) is recommended for diagnosis in patients with suspected paroxysmal hemicrania 1
- Gastrointestinal protection should be considered for patients on long-term indomethacin therapy
- Unlike migraine, paroxysmal hemicrania attacks are much shorter and more frequent
- Unlike cluster headache, paroxysmal hemicrania shows an absolute response to indomethacin
- Some patients may require long-term prophylactic treatment as the condition can be chronic
When evaluating a patient with suspected paroxysmal hemicrania, focus on attack duration, frequency, autonomic features, and response to indomethacin as the key diagnostic elements.